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INTRODUCTION:
Strontium plays important role in stimulating the growth of 
osteoblasts and enhancing the formation of new bone. Therefore, a 
strontium related compound - strontium ranelate (SR) has recently been 
suggested for use as a daily supplement to treat osteoporosis. However, 
the true effect of strontium to the stability of hydroxyapatite (HAp) has 
not been well understood yet, such as why higher concentration of 
strontium was normally detected in new bone, but seldom in old bone. In 
particular, strontium-substituted apatite was widely reported much 
higher soluble than pure HAp, although some report postulated that 
Sr40-HAp may be more stable than pure HAp, thus HAp should be the 
stable phase, not a strontium-substituted apatite. The most explanation 
was only attributed to calcium ion easily substituted by strontium ion on 
bone surface, but lacking of thermodynamic principle to support it.
Therefore a recent reported solid titration method has re-checked the
strontium system and found solubility of strontium-substituted apatite 
indeed increased with increase of strontium content (Fig. 1), the 
formation of such phase therefore seems not to be thermodynamically 
favored, which may be a kinetic issue. Thus, the solid titration method 
by seeding biological apatite in SBF solution may simulate the effect of 
strontium in human body and help to understand why strontium-
substituted apatite was formed as new bone.
Fig. 1 Solubility isotherms of strontium-substituted apatite by solid 
titration method (Acta Biomaterialia, submitted)
OBJECTIVE:
To examine the effect of strontium to the stability of biological apatite 
in SBF solution with different strontium concentration by solid titration
MATERIALS AND METHODS:
Solid titration method was use to conduct the seeding experiment. ~1 
mg biological apatite (rat bone; calcined at 600 oC to remove organic 
phase) was respectively added into 600 mL SBF solution containing 
different strontium concentration (0.05, 0.1, 0.5, 1, 5 mM), the solution 
was stirred by a magnetic bar at 37.0 ± 0.1 oC and monitored by a low-
angle laser-scattering system, after 10d, the precipitates were separated 
by centrifugation and washed by 2-3 droplets deionized water twice, and 
dried at 50 oC over night. XRD, SEM, TEM and EDX were respectively 
used to analyze the precipitates. 
RESULTS:
Biological apatite (rat bone) was characterized as fine carbonate 
apatite around 40 nm. After suspended in SBF for 10d, the crystal was 
found to grow preferred alignment of the c-axis. No appreciable 
difference of the precipitates was detected when strontium concentration 
below 0.1 mM in SBF solution (Fig. 2), the precipitate was only 
identified as carbonate apatite, where no strontium was detectable; 
however, significantly larger crystal was formed when strontium 
concentration raised to 0.5 mM, but crystal growth without preferred 
alignment, where strontium was detected in the precipitates (Fig. 2). In 
addition, more strontium was incorporated into crystal structure with the 
increase of strontium concentration in SBF solution, the phase was 
therefore identified as strontium-substituted apatite.
Fig. 2  Precipitates from SBF solution at 37 oC with different strontium 
concentration.
DISCUSSION:
SBF is a metastable solution, greatly supersaturated with respect to 
HAp, therefore the nucleation was driven by only adding 1 mg titrant as 
a seed. The growth of biological apatite in SBF solution was found to 
along c-axis, possibly due to the negative surface charge acting as a 
template for deposition of HAp in which the (002) plane had a preferred 
alignment, consistent with many observations in vitro. Meanwhile, 
strontium was found to play a key factor in the transformation of the 
mineral, because significant change of crystal was found when strontium 
concentration in SBF > 0.5 mM, although strontium-substituted apatite 
is much higher soluble than pure HAp according to previously reported, 
in particular, a Sr10-HAp was formed when [Sr] raised to 5 mM. 
Therefore, it is believed that the formation of strontium-substituted 
apatite is just a kinetic issue, although it is not a thermodynamically 
stable phase, it indeed nucleated easier, similar to octacalcium phosphate 
(OCP), although it is also not a stable phase, nucleating easier, therefore, 
OCP was normally detected in young bone, but gradually transforming 
to more stable phase HAp, thus seldom detected in mature bone. 
CONCLUSION:
Biological apatite grows with preferred alignment. Strontium plays 
important role in the transformation of mineral. Higher dose of strontium 
intake was significantly benefit to the formation of strontium-substituted 
apatite due to nucleation much easier than pure HAp, thus it may be the 
template to the formation of new bone.
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